Hiran C. Fernando

TL;DR: In this single institution experience, MIE offers results as good as or better than open operation in the authors' center with extensive minimally invasive and open experience, with a lower mortality rate (1.4%) and shorter hospital stay (7 days) than most open series.

TL;DR: This year’s winners are: Baystate Medical Center, Springfield, MA, Tufts University School of Medicine, Boston, Massachusetts, and University of Pennsylvania Medical center, Philadelphia, PA.

TL;DR: Although sublobar resection is thought to be associated with increased incidence of local recurrence when compared with lobectomy, a long-term analysis of the outcomes of these resections for stage I non-small cell lung cancer found no difference in disease-free survival between the two types of resection for stage IA patients but slightly worse disease- free survival for stage IB.

TL;DR: Anatomic segmentectomy outcomes compare favorably with standard lobectomy for stage I NSCLC and Margin/tumor ratios exceeding 1 were associated with a significant reduction in recurrence rates compared with ratios of less than 1, which should be considered as primary therapy when such margins are not obtainable with segmentectomy in the good-risk patient.

TL;DR: Minimally invasive esophagectomy is technically feasible and safe in the center, which has extensive minimally invasive and open esophageal experience, and should remain the standard until future studies conclusively demonstrate advantages of minimallyvasive approaches.